Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy. FE [Internet]. 2022 Dec. 23 [cited 2025 Oct. 29];23(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1539